Showing 1-15 of 15 results for "215643"
A Cruz et al.
Water science and technology : a journal of the International Association on Water Pollution Research, 44(4), 159-166 (2001-09-29)
A sequential anaerobic/aerobic treatment process was used to biodegrade the azo dye disperse blue 79 (DB79). The integrated process was successfully tested and operated for the mineralization of the DB79 dye until a concentration of 120 mg/l in 96 h....
Disperse Blue 1.
IARC monographs on the evaluation of carcinogenic risks to humans, 48, 139-148 (1990-01-01)
Sandra Loera-Serna et al.
Chemistry (Weinheim an der Bergstrasse, Germany), 25(17), 4398-4411 (2019-01-05)
The metal-organic framework (MOF) HKUST-1 was employed as an interaction matrix for fundamental loading studies of anthraquinone dyes. Chosen dyes were alizarin (A), alizarin S (AS), disperse blue 1 (B1), disperse blue 3 (B3), disperse blue 56 (B56) and purpurin...
Anna Sonnenburg et al.
Archives of toxicology, 86(5), 733-740 (2012-02-22)
Certain textile disperse dyes are known to cause allergic reactions of the human skin. Here, we examined 8 disperse dyes and 7 products of azo-cleavage of these dyes in an in vitro assay. We used the loose-fit coculture-based sensitization assay...
Nat. Toxicology Program
Report on Carcinogens (12th Ed. ) (2011)
C M Burnett et al.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 24(4), 269-276 (1986-04-01)
Disperse Blue 1 (containing 50% lignosulphonate dispersants) was fed to Fischer 344 rats at dietary levels of 0.01 and 0.1% for 19 months and at 1.0% for 6 months. Fischer 344 rats were also given the dye by gavage at...
Jeffrey J Yourick et al.
Toxicology and applied pharmacology, 195(3), 309-320 (2004-03-17)
Recent international guidelines for the conduct of in vitro skin absorption studies put forward different approaches for addressing the status of chemicals remaining in the stratum corneum and epidermis/dermis at the end of a study. The present study investigated the...
Davide Tamburro et al.
Journal of the American Chemical Society, 133(47), 19178-19188 (2011-10-18)
Many low-abundance biomarkers for early detection of cancer and other diseases are invisible to mass spectrometry because they exist in body fluids in very low concentrations, are masked by high-abundance proteins such as albumin and immunoglobulins, and are very labile....
Shuhua Li et al.
Nature biomedical engineering, 4(7), 704-716 (2020-04-02)
Strategies for selectively imaging and delivering drugs to tumours typically leverage differentially upregulated surface molecules on cancer cells. Here, we show that intravenously injected carbon quantum dots, functionalized with multiple paired α-carboxyl and amino groups that bind to the large...
Disperse Blue 1.
Report on carcinogens : carcinogen profiles, 11, III112-III113 (2004-01-01)
Disperse blue 1.
Report on carcinogens : carcinogen profiles, 12, 178-180 (2011-08-20)
Disperse Blue 1.
Report on carcinogens : carcinogen profiles, 10, 112-113 (2004-08-25)
M Saquib et al.
Journal of environmental management, 88(2), 300-306 (2007-05-11)
The photocatalytic degradation of a dye derivative, C.I. disperse blue 1 (1), has been investigated under UV light irradiation in the presence of TiO2 and H2O2 under a variety of conditions. The degradation was studied by monitoring the change in...
Yang Liu et al.
Journal of medicinal chemistry, 52(21), 6523-6526 (2009-10-21)
A series of mitoxantrone (MTX) analogues have been designed, synthesized, and evaluated for binding to and stabilizing a stem-loop structure that serves as a splicing regulatory element in the pre-mRNA of tau, which is involved in Alzheimer's and other neurodegenerative...
L C Haws et al.
Regulatory toxicology and pharmacology : RTP, 19(1), 80-96 (1994-02-01)
Disperse Blue 1 is an anthraquinone dye used at low levels in semipermanent hair color formulations. Dietary administration of Disperse Blue 1 in a National Toxicology Program (NTP) carcinogenesis bioassay produced transitional- and squamous-cell tumors, leiomyomas, and leiomyosarcomas of the...

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.